However, according to the most recent European Society of Cardiology guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, “genetic testing for SCN5A gene is recommended for probands with BrS” and “when a class IV or class V variant has been identified in a living or deceased individual with a condition that carries a risk of ventricular arrhythmia and sudden cardiac death, genetic testing of first-degree and symptomatic relatives and obligate carriers is recommended” (both class I, level of evidence C recommendations) [3]. Here, SCN5A is linked to Ventricular arrhythmia.